Talking to the Daily Mail, Dr Sarah Brewer, medical director of CBD oil producer Healthspan, discussed the medical conditions British patients are currently using CBD for :
“Cannabidiol oil has direct effects on the endocannabinoid system in the brain, enhancing the effects of other brain chemicals to reduce pain perception, relieve anxiety and stress, improve sleep and lift mood.
‘It is also a powerful antioxidant which suppresses inflammation.’
Raw hemp leaves, often used for teas, have already been banned under UK regulations. Cannabis and hemp products must be sold as finished products, meaning any raw cannabis product you see on the market is illegal
CBD would to be reclassified as a “novel food,”
A product is defined as a “novel food” if it cannot be shown to have been in safe, long term before 1997. Other supplements which were recently reclassified include Vitamin K and chia seeds.
The World Health Organisation (WHO), publishing research in the summer of 2018 which concluded that CBD is “generally well tolerated with a good safety profile.”
However, Britain’s FSA has pushed the European Food Standards Agency (EFSA) to reclassify CBD oil and, potentially, all other hemp extract products, as a “novel food.”
The FSA said it will now take action to block sales.
A spokesman explained:
“We are putting in transition measures to aid enforcement.”
What will this mean for those selling, and often making a living from, CBD?
Sellers of CBD are already prohibited from advertising, to even mentioning, Cannabidiol’s medical properties. These new rulings could bring in heavier crack downs on those blatantly flaunting the law.
Wider implications could be the closing of shops while this ban is in place, forcing patients to either buy CBD on the black market like regular cannabis, or worse, return to dangerous, life-threatening pharmaceutical medications.